The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
Condition(s):Rectal Cancer; Rectal Cancer Stage II; Rectal Cancer Stage IIILast Updated:February 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Rectal Cancer; Rectal Cancer Stage II; Rectal Cancer Stage IIILast Updated:February 12, 2024Recruiting
Condition(s):Colonic Neoplasms; Neoadjuvant Therapy; Immune Checkpoint InhibitorsLast Updated:November 13, 2023Recruiting
Condition(s):Hepatocellular Carcinoma Non-resectable; Portal Vein Tumor Thrombus; Immune Checkpoint InhibitorsLast Updated:September 15, 2023Recruiting
Condition(s):NMO Spectrum Disorder; Azathioprine Adverse ReactionLast Updated:June 9, 2023Completed
Condition(s):Locally Advanced Nasopharyngeal CarcinomaLast Updated:June 7, 2023Not yet recruiting
Condition(s):Coronary Artery Disease; CalcificationLast Updated:May 15, 2023Recruiting
Condition(s):Transfusion Dependent Beta-ThalassemiaLast Updated:May 9, 2023Recruiting
Condition(s):Transfusion-dependent α-ThalassemiaLast Updated:April 18, 2023Recruiting
Condition(s):Type2diabetesLast Updated:May 9, 2023Recruiting
Condition(s):Immunocompromised Patients; Pneumocystis Pneumonia; Diagnosis; Polymerase Chain ReactionLast Updated:November 4, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.